MARKET

IGC

IGC

IGC Pharma Inc
AMEX
0.2773
-0.0075
-2.63%
After Hours: 0.2750 -0.0023 -0.83% 17:57 02/27 EST
OPEN
0.2860
PREV CLOSE
0.2848
HIGH
0.2899
LOW
0.2752
VOLUME
149.04K
TURNOVER
--
52 WEEK HIGH
0.4985
52 WEEK LOW
0.2420
MARKET CAP
26.57M
P/E (TTM)
-3.5551
1D
5D
1M
3M
1Y
5Y
1D
IGC Pharma files utility patent applications covering AHA framework
TipRanks · 1d ago
IGC Pharma expands Phase 2 CALMA trial with new clinical site
TipRanks · 4d ago
IGC Pharma Price Target Raised to $5.00/Share From $4.75 by Ascendiant Capital
Dow Jones · 4d ago
IGC Pharma Is Maintained at Buy by Ascendiant Capital
Dow Jones · 4d ago
Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5
Benzinga · 4d ago
Weekly Report: what happened at IGC last week (0216-0220)?
Weekly Report · 4d ago
IGC Pharma issued notice of allowance by CIPO for IGC-AD1
TipRanks · 02/17 13:52
Weekly Report: what happened at IGC last week (0209-0213)?
Weekly Report · 02/16 09:34
More
About IGC
IGC Pharma, Inc. is a clinical-stage company, which is engaged in developing treatments for Alzheimer’s disease. The Company’s flagship drug, IGC-AD1, is an investigational drug tackles agitation, a major burden for patients and caregivers by addressing neuroinflammation. The Company operates through two segments: Life Sciences Segment and Infrastructure Segment. Its TGR-63 has demonstrated its potential to disrupt the progression of Alzheimer’s by targeting Aβ plaques, a key disease hallmark. The Company’s IGC-1C represents a potential breakthrough by targeting tau protein and neurofibrillary tangles, aiming to modify the disease course. Its IGC-M3 focuses on early intervention by inhibiting Aβ plaque formation, potentially slowing cognitive decline. Its LMP is designed to target multiple hallmarks of Alzheimer’s disease, including Aβ plaques and neurofibrillary tangles for a comprehensive therapeutic effect. It seeks to leverage artificial intelligence (AI) for Alzheimer's research.

Webull offers IGC Pharma Inc stock information, including AMEX: IGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IGC stock methods without spending real money on the virtual paper trading platform.